Upgrade to SI Premium - Free Trial

Insmed (INSM) Misses Q2 EPS by 2c

November 3, 2016 8:06 AM

Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.61), $0.02 worse than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Insmed (INSM) click here.

Categories

Earnings